Cargando…
Modeling Canadian Quality Control Test Program for Steroid Hormone Receptors in Breast Cancer: Diagnostic Accuracy Study
The Canadian Immunohistochemistry Quality Control program monitors clinical laboratory performance for estrogen receptor and progesterone receptor tests used in breast cancer treatment management in Canada. Current methods assess sensitivity and specificity at each time point, compared with a refere...
Autores principales: | Pérez, Teresa, Makrestsov, Nikita, Garatt, John, Torlakovic, Emina, Gilks, C. Blake, Mallett, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106078/ https://www.ncbi.nlm.nih.gov/pubmed/26200834 http://dx.doi.org/10.1097/PAI.0000000000000249 |
Ejemplares similares
-
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults †
por: Bebb, D. Gwyn, et al.
Publicado: (2021) -
Breast Cancer: Targeting of Steroid Hormones in Cancerogenesis and Diagnostics
por: Valko-Rokytovská, Marcela, et al.
Publicado: (2021) -
Diagnostic accuracy of the different hormonal tests used for the diagnosis of autonomous cortisol secretion
por: Araujo-Castro, Marta, et al.
Publicado: (2021) -
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)
por: Cheung, Carol C., et al.
Publicado: (2019) -
Accuracy of Diagnostic Tests
por: Santini, Ario, et al.
Publicado: (2021)